Annick Barbaud, Lene Heise Garvey, Maria Torres, Jose Julio Laguna, Alessandra Arcolaci, Patrizia Bonadonna, Kathrin Scherer Hofmeier, Anca Mirela Chiriac, Josefina Cernadas, Jean Christoph Caubet, Knut Brockow
In drug hypersensitivity, drug provocation testing (DPT), also called drug challenge, is the gold standard for investigation. In recent years, risk stratification has become an important tool for adjusting the diagnostic strategy to the perceived risk, whilst still maintaining a high level of safety for the patient. Skin tests are recommended before DPT but may be omitted in low-risk patients. The task force suggests a strict definition of such low-risk patients in children and adults. Based on experience and evidence from studies of allergy to beta-lactam antibiotics, an algorithm on how to adjust DPT to the risk, and when to omit skin tests before DPT, is presented...
December 28, 2023: Allergy